Skip to playerSkip to main contentSkip to footer
  • 11/14/2024
This session will cover the major routes to regulatory approval in the EU and US with a focus on Intended Use for Software as a Medical Device (SaMD), Good Machine Learning Practice (GMLP), and Post Market Surveillance (PMS).

Recommended